Cladribine (Fresenius Kabi USA, LLC)
Welcome to the PulseAid listing for the Cladribine drug offered from Fresenius Kabi USA, LLC. This Purine Antimetabolite [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Fresenius Kabi USA, LLC |
| NON-PROPRIETARY NAME: | CLADRIBINE |
| SUBSTANCE NAME: | CLADRIBINE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Purine Antimetabolite [EPC] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2004-12-01 |
| END MARKETING DATE: | 0000-00-00 |
Cladribine HUMAN PRESCRIPTION DRUG Details:
| Item Description | Cladribine from Fresenius Kabi USA, LLC |
| LABELER NAME: | Fresenius Kabi USA, LLC |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 1(mg/mL) |
| START MARKETING DATE: | 2004-12-01 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 63323-140_bf171945-d77a-4e9a-a4f1-de363d946c0f |
| PRODUCT NDC: | 63323-140 |
| APPLICATION NUMBER: | ANDA076571 |
Other CLADRIBINE Pharmaceutical Manufacturers / Labelers:
